Condition: Colorectal Cancer; Lung Cancer · Sponsor: Teclison Ltd.
Patients with refractory metastatic colorectal cancer or non-small cell lung cancer with liver metastasis treated with Trans-arterial Tirapazamine Embolization along with Pembrolizumab.
This description comes directly from the study's public registry record.
Ray Lee, MD. PhD. · 8043341076 · ray.lee01@teclison.com
Chiwei Lu · chiwei.lu4@teclison.com
Always discuss trial participation with your own doctor first.
| University of California, Irvine Medical Center | Orange, California, United States | Recruiting |
| China Medical University Hsinchu Hospital | Hsinchu, Taiwan | Recruiting |
| Chung Shan Medical University Hospital | Taichung, Taiwan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04701476